CHARACTERIZATION AND MOLECULAR DOCKING OF CINNAMIC ACID DERIVATIVES: POTENTIAL INHIBITORS OF CYCLOOXYGENASE ENZYMES

Authors

  • SAMUEL J BUNU Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Bayelsa, Nigeria,
  • DEGHINMOTEI ALFRED-UGBENBO Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Bayelsa Medical University, Yenagoa, Bayelsa, Nigeria,
  • OYEINTONBARA MIEDIEGHA Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, Niger Delta University, Wilberforce Island, Bayelsa, Nigeria,
  • HARUNA BABA Department of Pharmaceutical and Medicinal Chemistry, Faculty of Pharmacy, University of Calabar, Calabar, Cross River State, Nigeria.

DOI:

https://doi.org/10.22159/ijls.2023.v11i1.49501

Keywords:

Anti-inflammatory, inflammation, Cinnamic acid, cyclo-oxygenase, molecular docking

Abstract

Objective: The pathology of every disease passes through the inflammation stage; hence, the design and optimization of potential lead compounds as anti-inflammatory agents is still a significant part of medicinal chemistry globally.

Methods: In this study, we designed, synthesized, and characterized some cinnamic acid derivatives and performed molecular docking of the derivatives on the human cyclooxygenase-1 (COX-1) enzyme.

Results: The elemental analysis showed the presence of different functional groups. Molecular docking was performed on the active sites of COX-1 (PDB ID: 6Y3C). The derivatives as well as the standard compound, were observed to interact mainly with the arginine residue of the target protein. The dioxomethylene substituted derivative showed the highest binding affinity, compared with other derivatives, including the standard drug (−6.8 kcal/mol).

Conclusion: The binding affinity observed in the cinnamic derivatives, and biological activities correlations revealed that compounds with the dioxomethylene group would be good anti-inflammatory lead molecules, as they demonstrated high affinity to the target protein and biological activities. Thus, these compounds can serve as potential lead compounds for the design, and development of effective anti-inflammatory agents, targeted to inhibit the human COX-1 enzyme involved in biological inflammatory mechanisms.

References

Chandra S, Roy A, Jana M, Pahan K. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model. Neurobiol Dis 2019;124:379-95.

Ruwizhi N, Aderibigbe BA. Cinnamic acid derivatives and their biological efficacy. Int J Mol Sci 2020;21:5712.

Yilmaz S, Sova M, Ergün S. Antimicrobial activity of trans-cinnamic acid and commonly used antibiotics against important fish pathogens and nonpathogenic isolates. J Appl Microbiol 2018;125:1714-27.

Rodrigues MP, Tomaz DC, de Souza LA, Onofre TS, de Menezes WA, Almeida-Silva J, et al. Synthesis of cinnamic acid derivatives and leishmanicidal activity against Leishmania braziliensis. Eur J Med Chem 2019;183:111688.

Jacob BB, Oluwadiya JO. Synthesis, Characterization and evaluation of Anti-inflammatory and antimicrobial properties of some cinnamic acid derivatives. Niger J Pharm Res 2020;16:1-8.

Bacchi S, Palumbo P, Sponta A, Coppolino MF. Clinical pharmacology of non-steroidal anti-inflammatory drugs: A review. Antiinflamm Antiallergy Agents Med Chem 2012;11:52-64.

Stoff JS. Prostaglandins and hypertension. Am J Med 1986;80:56-61.

Zappavigna S, Cossu AM, Grimaldi A, Bocchetti M, Ferraro GA, Nicoletti GF, et al. Anti-inflammatory drugs as anticancer agents. Int J Mol Sci 2020;21:2605.

Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998;47 Suppl 2:S78-87.

Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol 2020;180:114147.

Hawkey CJ. Non-steroidal anti-inflammatory drug gastropathy: Causes and treatment. Scand J Gastroenterol Suppl 1996;220:124-7.

Umemori Y, Handa K, Sakamoto S, Kageyama M, Iijima T. QSAR model to predict Kp,uu,brain with a small dataset, incorporating predicted values of related parameter. SAR QSAR Environ Res 2022;33:885-97.

Verma J, Khedkar VM, Coutinho EC. 3D-QSAR in drug design--a review. Curr Top Med Chem 2010;10:95-115.

Bunu JS, Ebeshi B, Ere D. Quantification of efavirenz plasma levels and associated adverse reactions using simple reversed-phase HPLC technique. Arab J Med Sci 2020;4:9-12.

Sawazaki T, Sohma Y, Kanai M. Knoevenagel condensation between 2-methyl-thiazolo[4,5-b]pyrazines and aldehydes. Chem Pharm Bull (Tokyo) 2022;70:82-4.

Quest Graph™ IC50 Calculator. AAT Bioquest, Inc. (2023). Retrieved from: https://www.aatbio.com/tools/ic50-calculator.

Salam NK, Adzhigirey M, Sherman W, Pearlman DA. Structure-based approach to the prediction of disulfide bonds in proteins. Protein Eng Des Sel 2014;27:365-74.

Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and autodock/vina. J Comput Aided Mol Des 2010;24:417-22.

Miciaccia M, Belviso BD, Iaselli M, Cingolani G, Ferorelli S, Cappellari M, et al. Three-dimensional structure of human cyclooxygenase (hCOX)-1. Sci Rep 2021;11:4312.

Chen Z, Zhang X, Peng C, Wang J, Xu Z, Chen K, et al. D3Pockets: A method and web server for systematic analysis of protein pocket dynamics. J Chem Inf Model 2019;59:3353-8.

Shi Y, Zhang X, Mu K, Peng C, Zhu Z, Wang X, et al. D3Targets-2019- nCoV: A webserver for predicting drug targets and for multi-target and multi-site based virtual screening against COVID-19. Acta Pharm Sin B 2020;10:1239-48.

Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol 2011;31:986-1000.

Patil KR, Mahajan UB, Unger BS, Goyal SN, Belemkar S, Surana SJ, et al. Animal models of inflammation for screening of anti-inflammatory drugs: Implications for the discovery and development of phytopharmaceuticals. Int J Mol Sci 2019;20:4367.

Fujimori K. Prostaglandin D2 and F2α as regulators of adipogenesis and obesity. Biol Pharm Bull 2022;45:985-91.

Aykul S, Martinez-Hackert E. Determination of half-maximal inhibitory concentration using biosensor-based protein interaction analysis. Anal Biochem 2016;508:97-103.

Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al- Mssallem MQ. Flavonoids as potential anti-inflammatory molecules: A review. Molecules 2022;27:2901.

Zhou Y, Zheng J, Li Y, Xu DP, Li S, Chen YM, et al. Natural polyphenols for prevention and treatment of cancer. Nutrients 2016;8:515.

Published

27-10-2023

How to Cite

BUNU, S. J., ALFRED-UGBENBO, D., MIEDIEGHA, O., & BABA, H. (2023). CHARACTERIZATION AND MOLECULAR DOCKING OF CINNAMIC ACID DERIVATIVES: POTENTIAL INHIBITORS OF CYCLOOXYGENASE ENZYMES. Innovare Journal of Life Sciences, 11(1), 41–46. https://doi.org/10.22159/ijls.2023.v11i1.49501

Issue

Section

Original Article(s)